286 related articles for article (PubMed ID: 19406747)
1. Insulin receptor dysfunction impairs cellular clearance of neurotoxic oligomeric a{beta}.
Zhao WQ; Lacor PN; Chen H; Lambert MP; Quon MJ; Krafft GA; Klein WL
J Biol Chem; 2009 Jul; 284(28):18742-53. PubMed ID: 19406747
[TBL] [Abstract][Full Text] [Related]
2. Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers.
De Felice FG; Vieira MN; Bomfim TR; Decker H; Velasco PT; Lambert MP; Viola KL; Zhao WQ; Ferreira ST; Klein WL
Proc Natl Acad Sci U S A; 2009 Feb; 106(6):1971-6. PubMed ID: 19188609
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of calcineurin-mediated endocytosis and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors prevents amyloid beta oligomer-induced synaptic disruption.
Zhao WQ; Santini F; Breese R; Ross D; Zhang XD; Stone DJ; Ferrer M; Townsend M; Wolfe AL; Seager MA; Kinney GG; Shughrue PJ; Ray WJ
J Biol Chem; 2010 Mar; 285(10):7619-32. PubMed ID: 20032460
[TBL] [Abstract][Full Text] [Related]
4. Blocking the Interaction between EphB2 and ADDLs by a Small Peptide Rescues Impaired Synaptic Plasticity and Memory Deficits in a Mouse Model of Alzheimer's Disease.
Shi XD; Sun K; Hu R; Liu XY; Hu QM; Sun XY; Yao B; Sun N; Hao JR; Wei P; Han Y; Gao C
J Neurosci; 2016 Nov; 36(47):11959-11973. PubMed ID: 27881781
[TBL] [Abstract][Full Text] [Related]
5. Amyloid β-Derived Diffusible Ligands (ADDLs) Induce Abnormal Autophagy Associated with Aβ Aggregation Degree.
Wen J; Fang F; Guo SH; Zhang Y; Peng XL; Sun WM; Wei XR; He JS; Hung T
J Mol Neurosci; 2018 Feb; 64(2):162-174. PubMed ID: 29260451
[TBL] [Abstract][Full Text] [Related]
6. Protection against the synaptic targeting and toxicity of Alzheimer's-associated Aβ oligomers by insulin mimetic chiro-inositols.
Pitt J; Thorner M; Brautigan D; Larner J; Klein WL
FASEB J; 2013 Jan; 27(1):199-207. PubMed ID: 23073831
[TBL] [Abstract][Full Text] [Related]
7. Why Alzheimer's is a disease of memory: the attack on synapses by A beta oligomers (ADDLs).
Viola KL; Velasco PT; Klein WL
J Nutr Health Aging; 2008 Jan; 12(1):51S-7S. PubMed ID: 18165846
[TBL] [Abstract][Full Text] [Related]
8. Blocking IGF Signaling in Adult Neurons Alleviates Alzheimer's Disease Pathology through Amyloid-β Clearance.
Gontier G; George C; Chaker Z; Holzenberger M; Aïd S
J Neurosci; 2015 Aug; 35(33):11500-13. PubMed ID: 26290229
[TBL] [Abstract][Full Text] [Related]
9. Anti-ADDL antibodies differentially block oligomer binding to hippocampal neurons.
Shughrue PJ; Acton PJ; Breese RS; Zhao WQ; Chen-Dodson E; Hepler RW; Wolfe AL; Matthews M; Heidecker GJ; Joyce JG; Villarreal SA; Kinney GG
Neurobiol Aging; 2010 Feb; 31(2):189-202. PubMed ID: 18486276
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits.
Izzo NJ; Staniszewski A; To L; Fa M; Teich AF; Saeed F; Wostein H; Walko T; Vaswani A; Wardius M; Syed Z; Ravenscroft J; Mozzoni K; Silky C; Rehak C; Yurko R; Finn P; Look G; Rishton G; Safferstein H; Miller M; Johanson C; Stopa E; Windisch M; Hutter-Paier B; Shamloo M; Arancio O; LeVine H; Catalano SM
PLoS One; 2014; 9(11):e111898. PubMed ID: 25390368
[TBL] [Abstract][Full Text] [Related]
11. Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine.
De Felice FG; Velasco PT; Lambert MP; Viola K; Fernandez SJ; Ferreira ST; Klein WL
J Biol Chem; 2007 Apr; 282(15):11590-601. PubMed ID: 17308309
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's-associated Abeta oligomers show altered structure, immunoreactivity and synaptotoxicity with low doses of oleocanthal.
Pitt J; Roth W; Lacor P; Smith AB; Blankenship M; Velasco P; De Felice F; Breslin P; Klein WL
Toxicol Appl Pharmacol; 2009 Oct; 240(2):189-97. PubMed ID: 19631677
[TBL] [Abstract][Full Text] [Related]
13. Amyloid beta oligomers induce impairment of neuronal insulin receptors.
Zhao WQ; De Felice FG; Fernandez S; Chen H; Lambert MP; Quon MJ; Krafft GA; Klein WL
FASEB J; 2008 Jan; 22(1):246-60. PubMed ID: 17720802
[TBL] [Abstract][Full Text] [Related]
14. Days to criterion as an indicator of toxicity associated with human Alzheimer amyloid-beta oligomers.
Gandy S; Simon AJ; Steele JW; Lublin AL; Lah JJ; Walker LC; Levey AI; Krafft GA; Levy E; Checler F; Glabe C; Bilker WB; Abel T; Schmeidler J; Ehrlich ME
Ann Neurol; 2010 Aug; 68(2):220-30. PubMed ID: 20641005
[TBL] [Abstract][Full Text] [Related]
15. Alternations of central insulin-like growth factor-1 sensitivity in APP/PS1 transgenic mice and neuronal models.
Zhang B; Tang XC; Zhang HY
J Neurosci Res; 2013 May; 91(5):717-25. PubMed ID: 23401344
[TBL] [Abstract][Full Text] [Related]
16. Circulating Insulin-Like Growth Factor I is Involved in the Effect of High Fat Diet on Peripheral Amyloid β Clearance.
Herrero-Labrador R; Trueba-Saiz A; Martinez-Rachadell L; Fernandez de Sevilla ME; Zegarra-Valdivia JA; Pignatelli J; Diaz-Pacheco S; Fernandez AM; Torres Aleman I
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33352990
[TBL] [Abstract][Full Text] [Related]
17. Adenovirus-Mediated Transduction of Insulin-Like Growth Factor 1 Protects Hippocampal Neurons from the Toxicity of Aβ Oligomers and Prevents Memory Loss in an Alzheimer Mouse Model.
Selles MC; Fortuna JTS; Zappa-Villar MF; de Faria YPR; Souza AS; Suemoto CK; Leite REP; Rodriguez RD; Grinberg LT; Reggiani PC; Ferreira ST
Mol Neurobiol; 2020 Mar; 57(3):1473-1483. PubMed ID: 31760608
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers II: Sigma-2/PGRMC1 receptors mediate Abeta 42 oligomer binding and synaptotoxicity.
Izzo NJ; Xu J; Zeng C; Kirk MJ; Mozzoni K; Silky C; Rehak C; Yurko R; Look G; Rishton G; Safferstein H; Cruchaga C; Goate A; Cahill MA; Arancio O; Mach RH; Craven R; Head E; LeVine H; Spires-Jones TL; Catalano SM
PLoS One; 2014; 9(11):e111899. PubMed ID: 25390692
[TBL] [Abstract][Full Text] [Related]
19. Neuronal IGF-1 resistance reduces Abeta accumulation and protects against premature death in a model of Alzheimer's disease.
Freude S; Hettich MM; Schumann C; Stöhr O; Koch L; Köhler C; Udelhoven M; Leeser U; Müller M; Kubota N; Kadowaki T; Krone W; Schröder H; Brüning JC; Schubert M
FASEB J; 2009 Oct; 23(10):3315-24. PubMed ID: 19487308
[TBL] [Abstract][Full Text] [Related]
20. The role of neuronal insulin/insulin-like growth factor-1 signaling for the pathogenesis of Alzheimer's disease: possible therapeutic implications.
Zemva J; Schubert M
CNS Neurol Disord Drug Targets; 2014 Mar; 13(2):322-37. PubMed ID: 24059318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
